Cargando…

BSCI-21 COX4I1 EXPRESSION IN BRAIN METASTASES

BACKGROUND: COX4I1 (Cytochrome C oxidase, subunit 4, isoform 1) is a mitochondrial enzyme involved in the process of switching from glycolysis to oxidative phosphorylation. A previously published prospective biomarker study in glioblastoma cells found that Cytochrome C oxidase (CcO) activity was ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saad, Mahak, Jones, Karra, Loeffler, Bradley, Mott, Sarah, Griguer, Corinne, Monga, Varun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354161/ http://dx.doi.org/10.1093/noajnl/vdac078.019

Ejemplares similares

BSCI-05 REPURPOSING PROPOFOL FOR THE TREATMENT OF BRAIN METASTASES
por: Penning, Donald, et al.
Publicado: (2022)

BSCI-13. MTH1 expression is upregulated in brain metastases of malignant melanoma
por: Timmer, Marco
Publicado: (2021)

BSCI-14. tGLI1 is an actionable therapeutic target in breast cancer brain metastases
por: Doheny, Daniel, et al.
Publicado: (2021)

BSCI-06 COMPREHENSIVE ANALYSIS OF THE IMMUNOGENOMICS OF TRIPLE NEGATIVE BREAST CANCER BRAIN METASTASES FROM LCCC1419
por: Van Swearingen, Amanda, et al.
Publicado: (2022)

BSCI-02 CSF PROTEOMICS AS A MINIMALLY-INVASIVE STRATEGY FOR DISTINGUISHING BRAIN METASTASES FROM OTHER PRIMARY BRAIN MALIGNANCIES
por: Mansouri, Alireza, et al.
Publicado: (2022)

BSCI-10. Invasive growth of brain metastases is driven by cancer cell-pSTAT3+ reactive astrocyte crosstalk
por: Dankner, Matthew, et al.
Publicado: (2021)

BSCI-18 ESTROGEN-DEPLETION DECREASES PROGRESSION OF ER¯ BRAIN METASTASES BY PROMOTING AN ANTI-TUMORAL LOCAL IMMUNE RESPONSE
por: Contreras-Zarate, Maria, et al.
Publicado: (2022)

BSCI-04 TARGETING THE PI3K-MTOR PATHWAY TO TREAT UBE2C-DRIVEN BRAIN METASTASES
por: Paisana, Eunice, et al.
Publicado: (2022)

BSCI-16. Olfactory receptor 5B21 drives breast cancer metastasis
por: Li, Mao, et al.
Publicado: (2021)

BSCI-09. Multiomic single cell analysis reveals emerging principles of tumor immune microenvironment inherent to NSCLC brain metastases
por: Wen, Lei, et al.
Publicado: (2021)

BSCI-07. Multiomics characterization of brain metastases in multiple histologies identifies enrichment of oxidative phosphorylation as a promising therapeutic target
por: Fukumura, Kazutaka, et al.
Publicado: (2021)

BSCI-19. Therapeutic intervention of lung-, breast-, and melanoma-brain metastasis
por: Kieliszek, Agata, et al.
Publicado: (2021)

BSCI-01. Small RNAseq analysis of microRNAs in brain metastasis
por: Jancalek, Radim, et al.
Publicado: (2021)

BSCI-12. Inhibition of melanoma brain metastasis by targeting miR-146a
por: Wang, Jiwei, et al.
Publicado: (2021)

BSCI-02. METPlatform identifies brain metastasis vulnerabilities and predicts patient response to therapy
por: Zhu, Lucía, et al.
Publicado: (2021)

BSCI-20. THERAPEUTIC TARGETING OF HLA-G IN BRAIN METASTASES
por: Singh, Sheila, et al.
Publicado: (2019)

BSCI-04. Tumor-educated platelets promote breast cancer brain metastasis and therapeutic resistance
por: Tabet, Elie, et al.
Publicado: (2021)

BSCI-18. Identifying novel drivers of lung-to-brain metastasis through in vivo functional genomics
por: Aghaei, Nikoo, et al.
Publicado: (2021)

BSCI-17. Targeting SIRPα as a therapeutic strategy for the treatment of breast cancer brain metastasis
por: Stirling, Elizabeth R, et al.
Publicado: (2021)

BSCI-07 ACETYL-AMANTADINE AS A DIAGNOSTIC BIOMARKER IN PATIENTS WITH GLIOBLASTOMA
por: Mann, Anmol, et al.
Publicado: (2022)

BSCI-07. BONE MARROW T-CELL SEQUESTRATION IN THE SETTING OF BRAIN METASTASES
por: Chongsathidkiet, Pakawat, et al.
Publicado: (2019)

BSCI-06. Phage display biopanning identifies Amot regulating cell motility in brain metastasis-initiating cells
por: She, Chunhua, et al.
Publicado: (2021)

BSCI-11. Targeting PI3K/Akt/mTOR pathway to prevent melanoma brain metastasis
por: Tehranian, Cedric, et al.
Publicado: (2021)

BSCI-22 DETERMINING THE EFFECT OF NOVEL SMALL MOLECULE DRUGS AGAINST THE MIGRATION OF BRAIN METASTASIS INITIATING CELLS (BMICS)
por: Mobilio, Daniel, et al.
Publicado: (2022)

BSCI-23 ANEUPLOIDY PROFILING IN GLIOBLASTOMA IDENTIFIES MECHANISMS OF DISEASE PROGRESSION AND TREATMENT VULNERABILITIES
por: Jermakowicz, Anna, et al.
Publicado: (2022)

BSCI-05. ABL2-HSF1-E2F signaling axis promotes lung adenocarcinoma brain metastasis
por: Pendergast, Ann Marie, et al.
Publicado: (2021)

BSCI-03 THE ROLE OF LONP1 IN DRIVING ENHANCED PMT IN THE ‘LEADING EDGE’ NICHE IN GLIOBLASTOMA
por: Douglas, Christopher, et al.
Publicado: (2022)

BSCI-08 NEURONAL MIMICRY PROMOTES BREAST CANCER LEPTOMENINGEAL METASTASIS FROM BONE MARROW
por: Whiteley, Andrew, et al.
Publicado: (2022)

BSCI-12. COMPREHENSIVE GENOMIC ANALYSIS OF BRAIN METASTASES FROM MULTIPLE CANCER TYPES
por: Fukumura, Kazutaka, et al.
Publicado: (2019)

BSCI-19 A LENTIVIRAL CRISPR SCREEN FOR EPIGENETIC MODULATORS OF ANTIGENS TARGETED BY CAR T CELLS IN GLIOBLASTOMA
por: Jordan Walter, T, et al.
Publicado: (2022)

BSCI-20 STING EPIGENETIC SILENCING IN GLIOMAS CAN BE RESCUED BY METHYLTRANSFERASE INHIBITION: IMPLICATIONS FOR NOVEL THERAPEUTIC APPROACHES
por: Low, Justin, et al.
Publicado: (2022)

RADI-21. Feasibility of Gamma Knife Surgery for patients with 20 or more brain metastases
por: Jiani Liu, Sherry, et al.
Publicado: (2021)

BSCI-04. TARGETING TRIPLE-NEGATIVE BREAST CANCER BRAIN METASTASES WITH A RE-ENGINEERED LUPUS AUTOANTIBODY
por: Zhang, Shenqi, et al.
Publicado: (2019)

BSCI-02. tGLI1 IS A NOVEL, ACTIONABLE TARGET FOR THE TREATMENT OF BREAST CANCER BRAIN METASTASES
por: Doheny, Daniel, et al.
Publicado: (2019)

BSCI-09. MECHANISMS OF ENHANCED DRUG DELIVERY IN BRAIN METASTASES WITH FOCUSED ULTRASOUND-INDUCED BLOOD-TUMOR BARRIER DISRUPTION
por: Ferraro, Gino, et al.
Publicado: (2019)

BSCI-17. YOUNG AGE PROMOTES BREAST CANCER METASTASIS TO THE BRAIN
por: Wu, Alex, et al.
Publicado: (2019)

BSCI-23. TISSUE FACTOR SIGNALING ENHANCES METASTATIC BRAIN CANCER MALIGNANCY
por: Unruh, Dusten, et al.
Publicado: (2019)

BSCI-27. MELATONIN REDUCES MALIGNANCY OF BREAST CANCER BRAIN METASTATIC CELLS
por: Gil, Beatriz Fernandez, et al.
Publicado: (2019)

BSCI
por: Shannon Michael J
Publicado: (2004)

BSCI-25. THE ROLE OF THE IFNγ PATHWAY IN BREAST CANCER BRAIN METASTASIS FORMATION
por: Pedrosa, Route, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0rosoerqb5f3r02k7a53ad4a4t